HEALTH● LOW2h ago · Sep 28, 2026, 8:57 PM
Teva wins biosimilar approval of Amgen's Xgeva
Seeking Alpha Tech · global
Teva has received approval for a biosimilar version of Amgen's drug, Xgeva. This development introduces competition for the original drug and expands treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH46m agoVance, RFK Jr., Mike Tyson to speak at MAHA Summit in DCThe HillHEALTH1h agoPennsylvania surpasses 900 measles casesThe HillHEALTH1h agoMost Australians unprepared to lose loved onescessnockadvertiser.com.au · AustraliaHEALTH1h agoIf your body overresponds to infection , it can be fatal : Sepsis alert from doctors , survivorcalgarysun.com · Canada